International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome
- Jacobs, Bart C.
- Berg, Bianca
- Verboon, C. (Christine)
- Chavada, G. (Govindsinh)
- Cornblath, David
- Gorson, Kenneth
- Harbo, T. (Thomas)
- Hartung, H.P.
- Hughes, R.A.C. (Richard A. C.)
- Kusunoki, S. (Susumu)
- Doorn, Pieter
- Willison, H.J. (Hugh J.)
- Jacobs, Bart
- Hughes, Richard
- Cornblath, D.R.
- Gorson, K.C.
- Hartung, H.P.
- Kusunoki, S.
- Doorn, Pieter
- Willison, Hugh
- van Woerkom, M.
- van den Berg, B.
- Verboon, C.
- Roodbol, J.
- Jacobs, Bart
- Reisin, R.
- Reddel, S.W.
- Islam, Zhahirul
- Islam, B.
- Mohammad, Quazi
- Bergh, Paul
- Feasby, T.E.
- Wang, Y.Z.
- Harbo, T.
- Péréon, Y.
- Hartung, H.P.
- Lehmann, H.C.
- Dardiotis, E.
- Nobile-Orazio, Eduarde
- Kusunoki, Susumu
- Shahrizaila, N.
- Jacobs, B.C.
- van den Berg, B.
- Verboon, C.
- Bateman, K.
- Illa, Isabel
- Querol, Luis
- Hsieh, S.T.
- Willison, H.J.
- Chavada, G.
- Davidson, A.
- Gorson, K.C.
- Addington, J.M.
- Ajroud-Driss, S.
- Andersen, H.
- Antonini, G.
- Attarian, S.
- Badrising, Umesh
- Barroso, F.A.
- Benedetti, L.
- Beronio, A.
- Bianco, M.
- Binda, D.
- Briani, C.
- Bürmann, J.
- Bella, I.R.
- Bertorini, T.E.
- Bhavaraju-Sanka, R.
- Brannagan, T.H.
- Busby, M.
- Butterworth, S.
- Campagnolo, M.
- Casasnovas, C.
- Cavaletti, G.
- Chao, C.S.
- Chen, S.
- Chetty, S.
- Claeys, Tine
- Cohen, J.A.
- Conti, M.E.
- Cosgrove, J.S.
- Dalakas, Marinos
- Dimachkie, M.M.
- Dillmann, U.
- Domínguez González, C.
- Doppler, K.
- Dornonville de la Cour, C.
- Echaniz-Laguna, A.
- Eftimov, Filip
- Faber, C.G.
- Fazio, R.
- Fokke, Maureen
- Fujioka, T.
- Fulgenzi, E.
- Galassi, G.
- Garcia, T.
- Garnero, M.
- Garssen, Marcel
- Gijsbers, C.J.
- Gilchrist, J.M.
- Gilhuis, Job
- Goldstein, J.M.
- Goyal, N.
- Granit, V.
- Grapperon, A.
- Gutiérrez Gutiérrez, G.
- Gutmann, L.
- Hadden, Rob
- Holbech, J.V.
- Holt, J.K.L.
- Homedes Pedret, C.
- Htut, M.
- Jellema, K.
- Jericó Pascual, I.
- Kaida, Ken Ichi
- Karafiath, S.
- Katzberg, Hans
- Kiers, Henk
- Kieseier, Bernd
- Kimpinski, K.
- Kleyweg, R.P.
- Kokubun, N.
- Kolb, N.A.
- Kuitwaard, Krista
- Kuwabara, S.
- Kwan, J.Y.
- Ladha, S.S.
- Landschoff Lassen, L.
- Lawson, V.
- Ledingham, D.
- Léon Cejas, L.
- Luciano, C.A.
- Lucy, S.T.
- Lunn, Michael P. T.
- Magot, A.
- Manji, H.
- Marchesoni, A.
- Marfia, G.A.M.
- Márquez Infante, C.
- Martinez Hernandez, E.
- Mataluni, G.
- Mattiazi, M.
- McDermott, C.J.
- Meekins, G.D.
- Miller, J.
- Monges, M.S.
- Montero, M.C.J.
- Morís de la Tassa, G.
- Nascimbene, C.
- Neumann, C.
- Nowak, R.J.
- Orizaola Balaguer, P.
- Osei-Bonsu, M.
- Pan, E.B.L.
- Pardo Fernandez, J.
- Pasnoor, M.
- Pulley, M.T.
- Rajabally, Y.A.
- Rinaldi, Sabina
- Ritter, C.
- Roberts, R.C.
- Rojas-Marcos, I.
- Rudnicki, S.A.
- Sachs, G.M.
- Samijn, Johnny
- Santoro, L.
- Saperstein, D.S.
- Savransky, A.
- Schneider, H.
- Schenone, Andrea
- Sedano Tous, M.J.
- Sekiguchi, Y.
- Sheikh, K.A.
- Silvestri, N.J.
- Sindrup, S.H.
- Sommer, C.
- Stein, B.
- Stino, A.M.
- Spyropoulos, A.
- Srinivasan, J.
- Suzuki, H.
- Taylor, S.W.
- Tankisi, H.
- Tigner, D.
- Twydell, P.T.
- Valzania, F.
- van Damme, P.
- Kooj, Anneke
- Dijk, Gert
- van der Ree, T.
- Koningsveld, Rinske
- Varrato, J.D.
- Vermeij, Frederique
- Verschuuren, Jan
- Visser, Leendert
- Vytopil, M.V.
- Waheed, W.
- Wilken, M.
- Wilkerson, C.
- Wirtz, P.W.
- Yamagishi, Y.
- Yiu, E.M.
- Zhou, L.
- Zivkovic, Sasa
DOIAbstract
textabstractGuillain-Barré syndrome (GBS) is an acute polyradiculoneuropathy with a highly variable clinical presentation, course, and outcome. The factors that determine the clinical variation of GBS are poorly understood which complicates the care and treatment of individual patients. The protocol of the ongoing International GBS Outcome Study (IGOS), a prospective, observational, multicenter cohort study that aims to identify the clinical and biological determinants and predictors of disease onset, subtype, course and outcome of GBS is presented here. Patients fulfilling the diagnostic criteria for GBS, regardless of age, disease severity, variant forms, or treatment, can participate if included within 2 weeks after onset of weakness. In...
Add to ORKG